NASDAQ: ARWR
Arrowhead Pharmaceuticals, Inc.
Healthcare · Biotechnology
After hours: $86.00(+0.55%) · as of 6:36 PM ET
Market Cap
$12.05B
52w High
$95.49
52w Low
$15.01
P/E
-39.97
Volume
2.36M
Outstanding Shares
140.86M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 427.96% over the last year. Revenue grew 14.09% over the trailing twelve months. Operating margin moved from -21.74% to -35.67%. Free cash flow declined 630.14% over the trailing twelve months.
What the market seems to be pricing
The stock is rising despite deteriorating fundamentals and now sits at the 100th percentile of its historical P/FCF range. This is a momentum-driven move — the market may be front-running a recovery that has not yet appeared in reported numbers.
What would invalidate this read
Operating margin (currently -35.67%) would need to stabilize or improve to justify the move. This read is wrong if the next period shows operating metrics turning the corner. At that point the price would be anticipating real improvement rather than running ahead of it.
Company profile
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States.
Valuation
Stock splits
Every 10 shares became 1
Every 65 shares became 1
Profitability & growth
Analyst consensus
16
Buy
6
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2026
Q3 FY26 · EPS est -$1.28 · Revenue est $44.17M
View